company background image
4519 logo

Chugai Pharmaceutical TSE:4519 Stock Report

Last Price

JP¥5.93k

Market Cap

JP¥9.8t

7D

-2.2%

1Y

80.6%

Updated

27 Mar, 2024

Data

Company Financials +

Chugai Pharmaceutical Co., Ltd.

TSE:4519 Stock Report

Market Cap: JP¥9.8t

4519 Stock Overview

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Rewards

Risk Analysis

No risks detected for 4519 from our risk checks.

Chugai Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chugai Pharmaceutical
Historical stock prices
Current Share PriceJP¥5,927.00
52 Week HighJP¥6,697.00
52 Week LowJP¥3,203.00
Beta0.48
1 Month Change-1.35%
3 Month Change10.04%
1 Year Change80.59%
3 Year Change32.03%
5 Year Change143.58%
Change since IPO1,311.19%

Recent News & Updates

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Mar 01
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Recent updates

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Mar 01
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Shareholder Returns

4519JP PharmaceuticalsJP Market
7D-2.2%0.2%1.7%
1Y80.6%16.5%37.6%

Return vs Industry: 4519 exceeded the JP Pharmaceuticals industry which returned 16.6% over the past year.

Return vs Market: 4519 exceeded the JP Market which returned 38.6% over the past year.

Price Volatility

Is 4519's price volatile compared to industry and market?
4519 volatility
4519 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4519 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4519's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19257,771Osamu Okudahttps://www.chugai-pharm.co.jp

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases.

Chugai Pharmaceutical Co., Ltd. Fundamentals Summary

How do Chugai Pharmaceutical's earnings and revenue compare to its market cap?
4519 fundamental statistics
Market capJP¥9.75t
Earnings (TTM)JP¥325.47b
Revenue (TTM)JP¥1.11t

30.0x

P/E Ratio

8.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4519 income statement (TTM)
RevenueJP¥1.11t
Cost of RevenueJP¥413.31b
Gross ProfitJP¥698.06b
Other ExpensesJP¥372.59b
EarningsJP¥325.47b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 24, 2024

Earnings per share (EPS)197.82
Gross Margin62.81%
Net Profit Margin29.29%
Debt/Equity Ratio0%

How did 4519 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.